Nevirapine 200 mg Tablets

Nevirapine 200 mg tablet options

Nevirapine is an oral non-nucleoside reverse transcriptase inhibitor (NNRTI) used with other antiretroviral medicines to treat HIV-1 infection. We offer the product as a 200 mg tablet taken by mouth. There are no alternative strengths or dosage forms in this listing, so the main purchasing decision is which available package quantity corresponds to the amount authorized by the prescriber.

Our available quantities are 20, 30, 60, 90, 120, 180, 270, and 360 tablets. Package choice should begin with the prescribed quantity and expected duration of use. Price per tablet can help compare financially suitable options only after medical suitability, refill timing, and storage have been considered.

Package quantities and unit value

The comparison below presents our current package information, including exact prices and per-tablet values. It is the authoritative price reference within this guide and avoids relying on competitor prices, market averages, or estimated pharmacy costs.

Unit value may vary by quantity, but a lower unit price does not make a larger package medically preferable. Consider whether the quantity is consistent with the current prescription, whether treatment may be reassessed before all tablets are used, and whether the medicine can be stored correctly for the entire period. Do not obtain extra tablets to change the prescribed dose, extend treatment independently, or delay necessary clinical follow-up.

Which package quantity fits the treatment plan?

Adults generally use a 14-day lead-in period before moving to the usual maintenance schedule, but that dosing sequence does not by itself determine the correct package size. The appropriate quantity depends on the prescriber's directions, planned monitoring, remaining supply, and refill timing. Pediatric treatment requires individualized dosing based on body surface area, and a 200 mg tablet is not suitable for every child or every prescribed dose.

• Confirm that the listing matches the prescribed 200 mg oral tablet.
• Compare the authorized quantity with the package options rather than choosing solely by unit price.
• Account for tablets already on hand and avoid creating an unnecessary surplus.
• Consider the medicine's expiration date and storage requirements before choosing a quantity intended to last for an extended period.
• Ask the prescriber or pharmacist before changing refill timing or obtaining a different quantity from the one authorized.

Buying more tablets does not improve viral suppression or shorten treatment. Treatment effectiveness depends on taking the prescribed combination consistently and receiving the required clinical and laboratory monitoring.

Generic identity and related antiretrovirals

Nevirapine is the active ingredient and generic medicine name. It has also been marketed under the brand name Viramune. A generic Nevirapine tablet contains the same active ingredient, but manufacturers and inactive ingredients may differ. Brand or generic status should therefore be checked from the actual product label rather than inferred from the medicine name alone.

Nevirapine belongs to the NNRTI class. Other NNRTIs can have different food requirements, interaction profiles, resistance considerations, and dosing schedules. They are not direct shopping substitutes, and a change between antiretroviral medicines requires review of the complete HIV regimen.

This table provides general context and does not establish interchangeability. If a prescribed regimen includes a nucleoside reverse transcriptase inhibitor combination, our Combivir and Epivir listings provide information about catalog options containing other antiretroviral ingredients.

Established use in HIV-1 treatment

Nevirapine is used as part of combination antiretroviral therapy for HIV-1 and should not be used alone. Combining active medicines helps suppress viral replication and limits the emergence of resistance. Selection of the complete regimen depends on treatment history, resistance results, other health conditions, pregnancy considerations, and potential interactions.

Safety and effectiveness have been established in pediatric patients from 15 days to under 16 years of age, but pediatric dosing is based on body surface area and includes dose limits and a lead-in period. The 200 mg tablet in this listing may therefore be unsuitable for a child even when Nevirapine itself is prescribed. The medicine is not indicated for occupational or nonoccupational post-exposure prophylaxis.

Readers comparing related medicines can also visit our Anti Viral & Immunity category or our dedicated HIV category. Category placement is for catalog navigation and does not mean that products within a category are interchangeable.

How does Nevirapine work and how is it taken?

Nevirapine binds directly to HIV-1 reverse transcriptase, an enzyme the virus uses to copy its genetic material. This inhibits reverse transcriptase activity and interferes with viral replication. Because HIV can develop resistance rapidly when one active medicine is used alone, Nevirapine is prescribed with other antiretrovirals.

For adults, the labeled lead-in schedule is 200 mg once daily for the first 14 days, followed by 200 mg twice daily. The lead-in reduces the frequency of rash. If a rash occurs during this period, the dose should not be increased until the rash has resolved; extending once-daily dosing beyond 28 days requires medical reassessment because underdosing can promote resistance. If treatment is interrupted for more than seven days, the lead-in schedule is generally restarted under the prescriber's direction.

• Take the tablets exactly as prescribed, with or without food.
• Do not take extra tablets to compensate for a missed dose without professional advice.
• Do not stop Nevirapine or any companion antiretroviral independently.
• Keep laboratory and clinical monitoring appointments, especially during the first 18 weeks.
• Store the tablets at 68°F to 77°F; permitted excursions are 59°F to 86°F. Keep the bottle tightly closed and protect the tablets from moisture.

These instructions describe established labeling rather than an individualized regimen. Pediatric dosing, treatment interruptions, rash, liver test abnormalities, pregnancy, and changes to companion medicines require advice from the treating clinician.

Major safety considerations and interactions

Nevirapine carries a boxed warning for severe, potentially life-threatening liver toxicity and serious skin reactions. The highest-risk period is the first 18 weeks, although reactions can occur later. Intensive clinical and liver laboratory monitoring is required during early treatment. Symptoms such as yellowing of the skin or eyes, dark urine, severe fatigue, abdominal pain, fever, blistering, mouth sores, facial swelling, or a widespread rash require prompt medical evaluation.

Severe rash, rash accompanied by systemic symptoms, or clinical hepatitis can require permanent discontinuation. An isolated mild symptom or laboratory change should not be managed by changing the dose without the prescriber's assessment. Nevirapine is contraindicated in moderate-to-severe liver impairment and in people with known hypersensitivity to Nevirapine or a formulation component.

• Initiating treatment in women with CD4+ counts above 250 cells/mm3 is associated with a higher risk of symptomatic liver events. The prescriber must carefully assess the benefits and risks.
• Nevirapine may be used during pregnancy when clinically appropriate, but treatment initiation and monitoring require particular care. Pregnancy exposures may be reported to the Antiretroviral Pregnancy Registry.
• US labeling instructs mothers receiving Nevirapine not to breastfeed because of possible HIV-1 transmission, development of resistance in an infected infant, and potential serious adverse reactions.
• Nevirapine affects drug-metabolizing enzymes and can change the concentrations of other medicines. Rifampin is generally not recommended with it, and St. John's wort should not be used.
• Hormonal contraceptives should not be relied on as the sole method of contraception during treatment. A clinician can recommend an appropriate additional or alternative method.
• Fatigue, drowsiness, dizziness, and headache can affect driving or machinery use. Avoid these activities if such effects occur.

A complete medication review should include prescription medicines, over-the-counter products, vitamins, and herbal supplements. Interaction management may require a different companion medicine, additional monitoring, or another HIV regimen rather than a simple timing adjustment.

What does US prescription status mean?

Nevirapine tablets are prescription-only medicines in the United States. FDA approval applies to specific manufacturer applications and labeling; the active ingredient's established FDA status does not by itself identify the manufacturer or approval record for every tablet offered internationally.

Our current ordering policy does not require customers to submit a prescription during our ordering process. Our policy is separate from US regulatory status and does not replace evaluation, prescribing, or monitoring by a licensed clinician. Nevirapine should be used only according to a current treatment plan, particularly because it requires combination therapy, a specific lead-in schedule, and close early monitoring.

Official US prescribing information for individual Nevirapine products is available through the National Library of Medicine's DailyMed database. Suspected serious adverse events in the United States may be reported to FDA MedWatch.

Ordering and receiving the tablets

Before ordering, verify the product name, 200 mg strength, oral tablet form, and required quantity. Also confirm the delivery details entered with the order and ensure that someone can place the medicine into suitable storage after it arrives. We do not claim a specific shipping fee, dispatch time, or delivery date unless it is shown as part of the applicable order information.

1. Select a package quantity consistent with the current treatment plan.
2. Review the order details carefully before finalizing the purchase.
3. Contact our support team by email, online chat, or phone if you need help with catalog details or order status. Support is available 24/7.
4. Direct medication-specific questions to our pharmacist or the treating clinician.
5. When the order arrives, check the label, strength, tablet form, package condition, and expiration information before use.

If the delivered label does not match the expected medicine or strength, do not take the tablets until the discrepancy has been resolved.

A value-based package decision

The package-value comparison provides the current exact prices and per-tablet values for our available quantities. Use that information to compare financially suitable options only after confirming the medically appropriate quantity. The lowest unit price is not automatically the best choice if the quantity exceeds the authorized supply, may outlast a planned treatment review, or cannot be stored appropriately.

A sound decision balances four points: the prescribed 200 mg tablet, the authorized quantity, the monitoring and refill plan, and the current package value. Our support team can assist with catalog and ordering questions, while our pharmacist can address medication questions that arise before an order is completed.